Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung

BACKGROUND: A single‐agent of anti programmed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) therapy has been explored for resectable lung cancer before surgery. However, the effectiveness and safety of neoadjuvant programmed cell death 1 (PD‐1) blockade combined with chemotherapy hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuan, Sun, Wei, Zhang, Jie, Wang, Yang, Chen, Jinfeng, Liu, Xinying, Wang, Liang, Li, Shaolei, Lv, Chao, Lu, Fangliang, Zhang, Jianzhi, Hong, Yang, Xiao, Shanshan, Wang, Tao, Jiao, Raymond, Wang, Ziping, Qi, Liping, Li, Nan, Yang, Yue, Lin, Dongmei, Fang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807321/
https://www.ncbi.nlm.nih.gov/pubmed/34913597
http://dx.doi.org/10.1111/1759-7714.14280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807321/
https://www.ncbi.nlm.nih.gov/pubmed/34913597
http://dx.doi.org/10.1111/1759-7714.14280

Ejemplares similares